047920 On Other Exchanges
Symbol
Exchange
KOSDAQ

chem tech research inc (047920) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for CHEM TECH RESEARCH INC (047920)
\

Related News

No related news articles were found.

chem tech research inc (047920) Related Businessweek News

No Related Businessweek News Found

chem tech research inc (047920) Details

C-TRI Co., Ltd., a pharmaceutical company, develops peptide drugs in South Korea. It develops amino acids, antiviral drugs, and ionic liquids, as well as functional and anti-aging cosmetic products. The company also provides over the counter drugs and ethical the counter drugs, as well as contract manufacturing services. C-TRI Co., Ltd. was founded in 1998 and is headquartered in Namyangju, South Korea.

Founded in 1998

chem tech research inc (047920) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

chem tech research inc
C-TRI Co., Ltd., Annual General Meeting, Mar 29, 2019

C-TRI Co., Ltd., Annual General Meeting, Mar 29, 2019, at 09:00 Korea Standard Time.

C-TRI Co., Ltd., Annual General Meeting, Mar 23, 2018

C-TRI Co., Ltd., Annual General Meeting, Mar 23, 2018, at 09:00 Korea Standard Time.

DelSiTech Ltd and C-Tri Co. Ltd Sign Collaboration Agreement to Develop Innovative Drug Delivery Technology Product for Oncology

DelSiTech Ltd. and C-Tri Co. Ltd. have signed a Partnership and Collaboration Agreement to develop long-acting controlled release formulations with significant commercial potential. The first C-Tri product being developed in this partnership is NHM-CT-007, a peptide drug for oncology. DelSiTech's proprietary Silica Matrix technology allows the administration of parenteral controlled release drugs more precisely, safely and cost-effectively than with other alternative drug delivery technologies.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

047920 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 047920.
View Industry Companies
 

Industry Analysis

047920

Industry Average

Valuation 047920 Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact CHEM TECH RESEARCH INC, please visit www.c-tri.co.kr. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.